CFDE Data Portal | Search CREG2

	Label	Description
	CREG2 associations Collection (Entity type)	Associations for CREG2_associations
	CREG2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CREG2 Gene (Entity type)	ENSG00000175874 - cellular repressor of E1A stimulated genes 2
	Protein CREG2 Protein (Entity type)	A Protein
	KFGENEBIN:CREG2-variant-count CUI gene has variants CREG2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE101239 5 V 6 VALPROIC ACID MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE248769 1 V 0 SORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE158632 3 V 4 OXYQUINOLINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

CREG2 associations

Associations for CREG2_associations

CREG2 associations.tsv

A file from IDG as part of the Harmonizome project

CREG2

ENSG00000175874 - cellular repressor of E1A stimulated genes 2

Protein CREG2

A Protein

KFGENEBIN:CREG2-variant-count CUI gene has variants CREG2

A Knowledge Graph Assertion from Kids First

GSE101239 5 V 6 VALPROIC ACID MOUSE UP

A Gene Set from LINCS

GSE248769 1 V 0 SORAFENIB HUMAN UP

A Gene Set from LINCS

GSE158632 3 V 4 OXYQUINOLINE HUMAN UP

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 7 human dn

A Gene Set from LINCS

GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.